NEW YORK (GenomeWeb) – Mutations in the cancer-associated epidermal growth factor receptor (EGFR)-mitogen-activated protein kinase (MAPK) pathway lead to variations in the amount of regulatory adaptor proteins, rather than an increase in the main EGFR-MAPK pathway proteins themselves, according to a new study.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.